Prototype implementation test at Pharmalize Holding for social implementation of lunch box for improving Minor Health Complaints

Not Applicable

• Conditions: Japanese healthy adult workers

• Registration Number: JPRN-UMIN000047062
• Lead Sponsor: Medical Front Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-31
• Study Start: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects who are under physicians advice, treatment, and/or medication for schizophreni a depression, mania, neurological disorders, and/or sleep disorders. 2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities. 3. Subjects with major surgical history relevant to the digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc. 4. Subjects with implantable electronic medical devices. 5. Subjects who are under nutritional advice by a physician. 6. Pre- or post-menopausal women complaining of obvious physical changes. 7. Subjects who cannot continue to consume the test foods due to allergic reactions to drugs or foods (especially wheat and grass), and those who regularly use health foods including drugs and supplements that affect stress and sleep. 8. Subjects who regularly use medicines (sleeping pills, psychotropic drugs, etc.) or health foods/supplements (glycine, gamma-aminobutyric acid, L-serine, L-theanine, L-ornithine, reduced coenzyme Q10, etc.) that affect stress and sleep. 9. Heavy smokers, alcohol addicts or subjects with disordered lifestyle. 10. Subjects who donated either 400 ml whole blood within 16 wks (women), 12 wks (men), 200 ml whole blood within 4 wks, or blood components within 2 wks, prior to the current study. 11. Pregnant or lactating women or women who expect to be pregnant during this study. 12. Subjects who currently participate in other clinical trials or participated within the last 4 wks prior to the current study. 13. Any other medical and/or health reasons unfavorable to participation in the current study, as judged by the principal investigator.

Study & Design

• Study Type: Interventional
• Study Design: Not specified